Chemical Structure : ICB-7
货号: PC-28170Not For Human Use, Lab Use Only.
ICB-7 is a high affinity, direct Leukocyte immunoglobulin-like receptor B4 (LILRB4/ILT3) binder with MST Kd of 156 nM, binds D2 domain of ILT3, disrupts the ILT3-SCG2 (Secretogranin II) interaction and inhibits downstream SHP1, SHP2, and STAT3 signaling.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
ICB-7 is a high affinity, direct Leukocyte immunoglobulin-like receptor B4 (LILRB4/ILT3) binder with MST Kd of 156 nM, binds D2 domain of ILT3, disrupts the ILT3-SCG2 (Secretogranin II) interaction and inhibits downstream SHP1, SHP2, and STAT3 signaling.
ICB-7 produced concentration-dependent thermal stabilization of ILT3 with EC50 of 289 nM in CETSA assays.
ICB-7 inhibited the ILT3-SCG2 interaction in a concentration-dependent fashion with IC50 of 694 nM in TR-FRET competition assay.
ICB-7 significantly reduced SCG2-driven SHP1 and SHP2 phosphorylation in ILT3-expressing THP-1-derived macrophage-like cells stimulated with SCG2 with IC50 of 302 nM in ELISA assays.
ICB-7 strongly decreased p-STAT3 levels in a concentration-dependent manner with IC50 of 196 nM.
ICB-7 (1-25 uM) reverses SCG2-mediated immunosuppression in colorectal cancer and AML co-culture models.
ICB-7 (25 mg/kg, PO, QD) suppresses CT26 tumor growth and promotes anti-tumor immune activation in vivo.
| 分子量 | 440.95 | |
| 分子式 | C22H21ClN4O2S | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
1. Abdel-Rahman SA, et al. Eur J Med Chem. 2026 Sep 4;319:119295.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright